Self-injection refers to the process whereby individuals administer medication directly into their body using devices designed for personal use, often facilitated by pre-filled syringes, autoinjectors or pen injectors. This method is utilized primarily by patients who require regular dosages of medication for chronic conditions, enabling them to manage their treatment efficiently and independently.
The self-injections market consists of sales, by entities (organizations, sole traders and partnerships), of devices and formulations that are used for self-administration of medications, specifically designed to ensure safety, accuracy and ease of use in a home setting, catering to a wide array of medical needs and user capabilities.
The global self-injections market was valued at $6,723.8 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.
Patient Preference For Home Care Services
During the historic period, patient preference for home care services supported the growth of the self-injections market. Home care services encompass a range of supportive and medical services provided to individuals in the comfort of their own homes. Self-injections at home can also empower patients by allowing them to take responsibility for their treatment, providing flexibility in administering injections at home, work or even while traveling. According to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, the number of users utilizing home health care increased by 8.3% in 2021 to approximately 3 million, with 11,474 Medicare-certified home health organizations located across the US. Therefore, patient preference for home care services drove the growth of the self-injections market.
Focus On Enhancing User Experience By Combining Self-Injection Devices With An App
Companies operating in the self-injection market are focusing on launching self-injecting devices along with an app to enhance user experience. By integrating technology into their offerings, these companies aim to provide users with comprehensive solutions that not only facilitate the administration of medication but also offer features such as dosage reminders, injection tracking and connectivity with healthcare providers. For instance, in March 2022, Pfizer Inc., a US-based pharmaceutical industry company, launched ENBREL SmartClic in Australia, a new self-injecting device. This new device is accompanied by a smartphone app to enhance the self-injection experience for patients dealing with chronic inflammatory diseases. ENBREL SmartClic features an automated, reusable design with user-friendly elements like a one-button initiation, a larger grip compared to the Enbrel Auto-Injector and injection speed control. The device can be paired with a mobile app for optional features, including reminders, injection history recording, site tracking and streamlined reports, all accessible on the patient's smartphone and shareable with healthcare professionals.
The global self-injections market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 33.0% of the total market in 2022.
Self-Injections Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global self-injections market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for self-injections? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The self-injections market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider self-injections market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by route of administration, by dosage, by application and by distribution channel.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the self-injections market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by route of administration, by dosage, by application and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for self-injections providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Type: Devices; Formulations
- 2) By Application: Cancer; Autoimmune Diseases; Hormonal Disorders; Pain Management; Other Applications
- 3) By Distribution Channel: Hospital Pharmacies; Clinics; Chemists; Online Pharmacies
- 4) By Route Of Administration: Skin; Circulatory Or Musculoskeletal; Organs; Central Nervous System
- 5) By Dosage: Single Dose; Multi Dose
- Companies Mentioned: Pfizer Inc.; Becton Dickinson and Company; Ypsomed Holding AG; Eli Lilly and Company; Merck & Co. Inc
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; self-injections indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.